On December 14, 2021 Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information services, reported it has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South and North Carolina, Georgia and Florida (Press release, Quest Diagnostics, DEC 14, 2021, View Source [SID1234597183]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

With the acquisition, Quest broadens access to diagnostic innovation and insights empowering better health for more communities in the Southeast. The Labtech laboratory in Anderson joins the national network of Quest Diagnostics laboratories, making it the first full-service laboratory owned by Quest in South Carolina. The acquisition will also enable more physicians in the state to access diagnostic services directly from Quest through its Cleveland HeartLab cardiometabolic center of excellence and other laboratories in Atlanta, Tampa and Greensboro, North Carolina.

"Our acquisition of Labtech Diagnostics delivers on our Accelerate growth strategy in the Southeast and vision of a healthier world," said Steve Rusckowski, Chairman, CEO and President, Quest Diagnostics. "Establishing a laboratory in South Carolina will enable us to provide diagnostic insights empowering affordable care to more patients and providers while building on our growth aims in the region."